Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy

BACKGROUND: Paclitaxel chemotherapy frequently induces dose-limiting sensory axonal polyneuropathy. Given that sensory symptoms are challenging to assess objectively in clinical practice, an easily accessible biomarker for chemotherapy-induced polyneuropathy (CIPN) holds the potential to improve ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Huehnchen, Petra, Schinke, Christian, Bangemann, Nikola, Dordevic, Adam D., Kern, Johannes, Maierhof, Smilla K., Hew, Lois, Nolte, Luca, Körtvelyessy, Peter, Göpfert, Jens C., Ruprecht, Klemens, Somps, Christopher J., Blohmer, Jens-Uwe, Sehouli, Jalid, Endres, Matthias, Boehmerle, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986065/
https://www.ncbi.nlm.nih.gov/pubmed/35133982
http://dx.doi.org/10.1172/jci.insight.154395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986065/
https://www.ncbi.nlm.nih.gov/pubmed/35133982
http://dx.doi.org/10.1172/jci.insight.154395

Ejemplares similares